ClinicalTrials.gg
Drug

Methyl aminolevulinate clinical trials

Also written Metvix.

Includes 2 studies of Methyl aminolevulinate hydrochloride.

studies test it
18
open now
0
in phase 3
7
first study started
1999

How each study uses methyl aminolevulinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
27 Jul 2004 · METVIXIA · NDA 021415 (FDA, Drugs@FDA; as methyl aminolevulinate hydrochloride)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Metvix® cream
3
Methyl Aminolevulinate
3
Methyl 5-aminolevulinate hydrochloride
2
methyl-aminolevulinate
2
MAL Cream
2

Brand

Metvix
7

Development codes

RVG 31130
1

Other names

Methyl 5-aminolevulinate
1

Studies by the year they started

18 studies that test it; most in 2015 (3)

Studies that test methyl aminolevulinate, by start year
YearStudies
19991
20002
20071
20082
20091
20121
20132
20142
20153
20161
20171
20191

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
7
Phase 4
6
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 11

Galderma R&D (5) · Maastricht University Medical Center (2) · Biofrontera Bioscience GmbH (2) · Joint Authority for Päijät-Häme Social and Health Care (2) · Norwegian University of Science and Technology (1) · Centre Hospitalier Universitaire de Nīmes (1) · Fundación Dermabase (1) · Innovaderm Research Inc. (1)

Often tested with

Tested in the same studies.

Aminolevulinic Acid (5) · BF-200 ALA (3) · Fluorouracil (1)

Studies

Open first, then newest update. How each study uses methyl aminolevulinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Given beside what is tested · 5 — methyl aminolevulinate is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with methyl aminolevulinate

Codes

What other systems call methyl aminolevulinate · ClinicalTrials.gg INT004537

  • MeSH (NLM) C475457methyl 5-aminolevulinateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 585NM85KYMMETHYL AMINOLEVULINATEConfirmed FDA, NLM, Wikidata
  • RxNorm 337068Confirmed FDA, Wikidata
  • Wikidata Q619603methyl aminolevulinateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C76305Methyl AminolevulinateOne source FDA
  • DrugBank DB00992One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.